Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In Reply We respectfully disagree with Dr Rosansky on several key points and favor a more comprehensive approach to the care of older patients with CKD than he has proposed.
First, the current eGFR and the rate of future decline are each important in the care of older patients with CKD. Numerous studies show the current eGFR is related to a broad range of adverse outcomes beyond kidney failure, including cardiovascular disease, metabolic and hormonal complications, medication toxicity, infections, cognitive impairment, and frailty.1
Levey AS, Inker LA, Coresh J. Managing Chronic Kidney Disease in Older People—Reply. JAMA. 2016;315(3):307. doi:10.1001/jama.2015.16002
Customize your JAMA Network experience by selecting one or more topics from the list below.